Sydenham’s chorea: from pathophysiology to therapeutics

References

• Baizabal-Carvallo JF, Jankovic J. Movement disorders in autoimmune diseases. Mov Disord. 2012 Jul;27(8):935–946.
   PubMed Web of Science ®Google Scholar
• Mohammad SS, Ramanathan S, Brilot F, et al. Autoantibody-associated movement disorders. Neuropediatrics. 2013 Dec;44(6):336–345.
   PubMed Web of Science ®Google Scholar
• Cardoso F. Autoimmune choreas. J Neurol Neurosurg Psychiatry. 2017 May;88(5):412–417.
   PubMedGoogle Scholar
• Baizabal-Carvallo JF, Cardoso F. Chorea in children: etiology, diagnostic approach and management. J Neural Transm (Vienna). 2020 Oct;127(10):1323–1342.
   PubMed Web of Science ®Google Scholar
• Cardoso F, Eduardo C, Silva AP, et al. Chorea in fifty consecutive patients with rheumatic fever. Mov Disord. 1997 Sep;12(5):701–703.
   PubMed Web of Science ®Google Scholar
• Oosterveer DM, Overweg-Plandsoen WC, Roos RA. Sydenham’s chorea: a practical overview of the current literature. Pediatr Neurol. 2010 Jul;43(1):1–6.
   PubMed Web of Science ®Google Scholar
• Gewitz MH, Baltimore RS, Tani LY, et al. Revision of the Jones Criteria for the diagnosis of acute rheumatic fever in the era of Doppler echocardiography: a scientific statement from the American Heart Association. Circulation 2015 May 19;131(20):1806–1818.
   PubMed Web of Science ®Google Scholar
• Karthikeyan G, Guilherme L. Acute rheumatic fever. Lancet. 2018;392(10142):161–174.
   PubMed Web of Science ®Google Scholar
• Cunningham MW, Mimicry M. Autoimmunity, and infection: the cross-reactive antigens of group a streptococci and their sequelae. Microbiol Spectr. 2019 Jul;7(4):4.
   Web of Science ®Google Scholar
• Seckeler Md, Hoke TR. The worldwide epidemiology of acute rheumatic fever and rheumatic heart disease. Clin Epidemiol. 2011 Feb;22(3):67–84.
   Google Scholar
• Vasconcelos M, Vasconcelos L, Ribeiro V, et al. Incidence and predictors of stroke in patients with rheumatic heart disease. Heart. 2021;107(9):748–754.
   PubMedGoogle Scholar
• Wyber R, Wade V, Anderson A, et al. Rheumatic heart disease in Indigenous young peoples. Lancet Child Adolesc Health. 2021;5(6):437–446.
   PubMedGoogle Scholar
• Marino A, Cimaz R, Pelagatti MA, et al. Acute Rheumatic Fever: where Do We Stand? An Epidemiological Study in Northern Italy. Front Med (Lausanne). 2021;8:621668.
   PubMed Web of Science ®Google Scholar
• Kalil J, Rheumatic Fever: GL. A model of autoimmune disease due to molecular mimicry between human and pathogen proteins. Crit Rev Immunol. 2020;40(5):419–422.
   PubMed Web of Science ®Google Scholar
• Konig MF. The microbiome in autoimmune rheumatic disease. Best Pract Res Clin Rheumatol. 2020 Feb;34(1):101473.
   PubMed Web of Science ®Google Scholar
• Goodfellow JA, Willison HJ. Guillain-Barre syndrome: a century of progress. Nat Rev Neurol. 2016 Dec;12(12):723–731.
   PubMed Web of Science ®Google Scholar
• Swedo SE. Sydenham’s chorea A model for childhood autoimmune neuropsychiatric disorders. Jama. 1994 Dec 14;272(22):1788–1791.
   PubMed Web of Science ®Google Scholar
• Cunningham MW, Cox CJ. Autoimmunity against dopamine receptors in neuropsychiatric and movement disorders: a review of Sydenham chorea and beyond. Acta Physiol (Oxf). 2016 Jan;216(1):90–100.
   PubMed Web of Science ®Google Scholar
• Husby G, van de Rijn I, Zabriskie JB, et al. Antibodies reacting with cytoplasm of subthalamic and caudate nuclei neurons in chorea and acute rheumatic fever. J Exp Med. 1976 Oct 1;144(4):1094–1110.
   PubMed Web of Science ®Google Scholar
• Singer HS. Autoantibody-associated movement disorders in children: proven and proposed. Semin Pediatr Neurol. 2017 Aug; 24(3):168–179.
   PubMed Web of Science ®Google Scholar
• Husby G, Li L, Davis LE, et al. Antibodies to human caudate nucleus neurons in Huntington’s chorea. J Clin Invest. 1977 May;59(5):922–932.
   PubMed Web of Science ®Google Scholar
• Kirvan CA, Swedo SE, Heuser JS, et al. Mimicry and autoantibody-mediated neuronal cell signaling in Sydenham chorea. Nat Med. 2003 Jul 9;9(7):914–920.
   PubMed Web of Science ®Google Scholar
• Kirvan CA, Cox CJ, Swedo SE, et al. Tubulin is a neuronal target of autoantibodies in Sydenham’s chorea. J Immunol. 2007 Jun 1;178(11):7412–7421.
   PubMed Web of Science ®Google Scholar
• Brimberg L, Benhar I, Mascaro-Blanco A, et al. Behavioral, pharmacological, and immunological abnormalities after streptococcal exposure: a novel rat model of Sydenham chorea and related neuropsychiatric disorders. Neuropsychopharmacology. 2012 Aug;37(9):2076–2087.
   PubMed Web of Science ®Google Scholar
• Cox CJ, Sharma M, Leckman JF, et al. Brain human monoclonal autoantibody from sydenham chorea targets dopaminergic neurons in transgenic mice and signals dopamine D2 receptor: implications in human disease. J Immunol. 2013 Dec 1;191(11):5524–5541.
   PubMed Web of Science ®Google Scholar
• Kirvan CA, Swedo SE, Kurahara D, et al. Streptococcal mimicry and antibody-mediated cell signaling in the pathogenesis of Sydenham’s chorea. Autoimmunity. 2006 Feb;39(1):21–29.
   PubMed Web of Science ®Google Scholar
• Teixeira AL Jr., Guimaraes MM, Romano-Silva MA, et al. Serum from Sydenham’s chorea patients modifies intracellular calcium levels in PC12 cells by a complement-independent mechanism. Mov Disord. 2005 Jul;20(7):843–845.
   PubMed Web of Science ®Google Scholar
• Ben-Pazi H, Stoner JA, Cunningham MW. Dopamine receptor autoantibodies correlate with symptoms in Sydenham’s chorea. PLoS One. 2013;8(9):e73516.
   PubMed Web of Science ®Google Scholar
• Teixeira AL Jr., Maia DP, Cardoso F. UFMG Sydenham’s chorea rating scale (USCRS): reliability and consistency. Mov Disord. 2005 May;20(5):585–591.
   PubMed Web of Science ®Google Scholar
• Vasconcelos LPB, Vasconcelos MC, Nunes MDCP, et al. Sydenham’s chorea: an update on pathophysiology, clinical features and management. Expert Opinion on Orphan Drugs. 2019 Nev 02; 711:501–511.
   Web of Science ®Google Scholar
• Lotan D, Benhar I, Alvarez K, et al. Behavioral and neural effects of intra-striatal infusion of anti-streptococcal antibodies in rats. Brain Behav Immun. 2014 May;38:249–262.
   PubMed Web of Science ®Google Scholar
• Chain JL, Alvarez K, Mascaro-Blanco A, et al. Autoantibody biomarkers for basal ganglia encephalitis in sydenham chorea and pediatric autoimmune neuropsychiatric disorder associated with streptococcal infections. Front Psychiatry. 2020;11:564.
   PubMed Web of Science ®Google Scholar
• Church AJ, Cardoso F, Dale RC, et al. Anti-basal ganglia antibodies in acute and persistent Sydenham’s chorea. Neurology. 2002 Jul 23;59(2):227–231.
   PubMed Web of Science ®Google Scholar
• Morris-Berry CM, Pollard M, Gao S, et al. Anti-streptococcal, tubulin, and dopamine receptor 2 antibodies in children with PANDAS and Tourette syndrome: single-point and longitudinal assessments. J Neuroimmunol. 2013 Nov 15;264(1–2):106–113.
   PubMed Web of Science ®Google Scholar
• Singer HS, Mascaro-Blanco A, Alvarez K, et al. Neuronal antibody biomarkers for Sydenham’s chorea identify a new group of children with chronic recurrent episodic acute exacerbations of tic and obsessive compulsive symptoms following a streptococcal infection. PLoS One. 2015;10(3):e0120499.
   PubMed Web of Science ®Google Scholar
• Bejerot S, Klang A, Hesselmark E. The Cunningham Panel: concerns remain. Transl Psychiatry. 2019 Sep 10;9(1):224.
   PubMedGoogle Scholar
• Dean SL, Singer HS. Treatment of Sydenham’s Chorea: a Review of the Current Evidence. Tremor Other Hyperkinet Mov (N Y). 2017;7:456.
   PubMed Web of Science ®Google Scholar
• Giedd JN, Rapoport JL, Kruesi MJ, et al. Sydenham’s chorea: magnetic resonance imaging of the basal ganglia. Neurology. 1995 Dec;45(12):2199–2202.
   PubMed Web of Science ®Google Scholar
• Ekici A, Yakut A, Yimenicioglu S, et al. Clinical and neuroimaging findings of sydenham’s chorea. Iran J Pediatr. 2014 Jun;24(3):300–306.
   PubMed Web of Science ®Google Scholar
• Gumus H, Gumus G, Per H, et al. Diffusion-weighted imaging in Sydenham’s chorea. Childs Nerv Syst. 2013 Jan;29(1):125–130.
   PubMed Web of Science ®Google Scholar
• Ehrlich DJ, Walker RH. Functional neuroimaging and chorea: a systematic review. J Clin Mov Disord. 2017;4(1):8.
   PubMedGoogle Scholar
• Giorgio SM, Caprio MG, Galante F, et al. Clinical Value of Perfusion Abnormalities of Brain on Technetium-99m HMPAO Single-Photon Emission Computed Tomography in Children With Sydenham Chorea. J Child Neurol. 2017 Mar;32(3):316–321.
   PubMed Web of Science ®Google Scholar
• Dileepan T, Smith ED, Knowland D, et al. Group A Streptococcus intranasal infection promotes CNS infiltration by streptococcal-specific Th17 cells. J Clin Invest. 2016 Jan;126(1):303–317.
   PubMed Web of Science ®Google Scholar
• McAfoose J, Baune BT. Evidence for a cytokine model of cognitive function. Neurosci Biobehav Rev. 2009 Mar;33(3):355–366.
   PubMed Web of Science ®Google Scholar
• Teixeira AL Jr., Cardoso F, Souza AL, et al. Increased serum concentrations of monokine induced by interferon-gamma/CXCL9 and interferon-gamma-inducible protein 10/CXCL-10 in Sydenham’s chorea patients. J Neuroimmunol. 2004 May;150(1–2):419–422.
   PubMed Web of Science ®Google Scholar
• Torres KC, Rocha NP, Rezende VB, et al. Persistent Sydenham’s chorea is not associated with sustained lymphocyte dysfunction. Arq Neuropsiquiatr. 2016 Jan;74(1):5–9.
   PubMed Web of Science ®Google Scholar
• Alkan A, Kutlu R, Kocak G, et al. Brain MR spectroscopy in children with a history of rheumatic fever with a special emphasis on neuropsychiatric complications. Eur J Radiol. 2004 Mar;49(3):224–228.
   PubMed Web of Science ®Google Scholar
• Giray D, Hallioglu O. Are there any novel markers in acute rheumatic fever: neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and monocyte-to-lymphocyte ratio. Cardiol Young. 2020 May;30(5):717–721.
   PubMed Web of Science ®Google Scholar
• Gray LA, D’Antoine HA, Tong SYC, et al. Genome-wide analysis of genetic risk factors for rheumatic heart disease in aboriginal australians provides support for pathogenic molecular mimicry. J Infect Dis. 2017 Dec 12;216(11):1460–1470.
   PubMed Web of Science ®Google Scholar
• Parks T, Mirabel MM, Kado J, et al. Association between a common immunoglobulin heavy chain allele and rheumatic heart disease risk in Oceania. Nat Commun. 2017 May;8(1):14946.
   PubMedGoogle Scholar
• Kilic A, Unuvar E, Tatli B, et al. Neurologic and cardiac findings in children with Sydenham chorea. Pediatr Neurol. 2007 Mar;36(3):456–464.
   PubMed Web of Science ®Google Scholar
• Sehar A, Nasir S, Seja A. Rheumatic chorea as the first presenting sign in a 13-year-old female child. Cureus. 2019 Aug 21;11(8):e5447.
   PubMed Web of Science ®Google Scholar
• Ayoub EM, Nelson B, Shulman ST, et al. Group A streptococcal antibodies in subjects with or without rheumatic fever in areas with high or low incidences of rheumatic fever. Clin Diagn Lab Immunol. 2003 Sep;10(5):886–890.
   PubMedGoogle Scholar
• Johnson DR, Kurlan R, Leckman J, et al. The human immune response to streptococcal extracellular antigens: clinical, diagnostic, and potential pathogenetic implications. Clin Infect Dis. 2010 Feb 15;50(4):481–490.
   PubMed Web of Science ®Google Scholar
• Bovenzi R, Conti M, Cerroni R, et al. Adult-onset sporadic chorea: real-world data from a single-centre retrospective study. Neurol Sci. 2021 May 26. https://doi.org/10.1007/s10072-021-05332-w.
   Google Scholar
• Silva GD, Parmera JB, Haddad MS. Acute chorea: case series from the emergency room of a Brazilian tertiary-level center. Arq Neuropsiquiatr. 2021 Mar;79(3):233–237.
   PubMed Web of Science ®Google Scholar
• Faustino PC, Terreri MT, Da Rocha AJ, et al. Clinical, laboratory, psychiatric and magnetic resonance findings in patients with Sydenham chorea. Neuroradiology. 2003 Jul;45(7):456–462.
   PubMed Web of Science ®Google Scholar
• Karalok ZS, Ozturk Z, Gunes A, et al. Sydenham Chorea: putaminal Enlargement. J Child Neurol. 2021 Jan;36(1):48–53.
   PubMed Web of Science ®Google Scholar
• de Teixeira AL, Cardoso F, Maia DP, et al. Frequency and significance of vocalizations in Sydenham’s chorea. Parkinsonism Relat Disord. 2009 Jan;15(1):62–63.
   PubMed Web of Science ®Google Scholar
• Teixeira AL, Cardoso F, Maia DP, et al. Sydenham’s chorea may be a risk factor for drug induced parkinsonism. J Neurol Neurosurg Psychiatry. 2003;74(9):1350–1351.
   PubMed Web of Science ®Google Scholar
• Barreto LB, Maciel RO, Maia DP, et al. Parkinsonian signs and symptoms in adults with a history of Sydenham’s chorea. Parkinsonism Relat Disord. 2012 Jun;18(5):1350–1351.
   PubMed Web of Science ®Google Scholar
• Teixeira AL, Jr., Maia DP, Cardoso F. [The initial testing and the discrimination property of the UFMG Sydenham's Chorea Rating Scale (USCRS)]. Arq Neuropsiquiatr. 2005 Sep;63(3B):825–827.
   Google Scholar
• Punukollu M, Mushet N, Linney M, et al. Neuropsychiatric manifestations of Sydenham’s chorea: a systematic review. Dev Med Child Neurol. 2016 Jan;58(1):16–28.
   PubMed Web of Science ®Google Scholar
• Swedo SE, Rapoport JL, Cheslow DL, et al. High prevalence of obsessive-compulsive symptoms in patients with Sydenham’s chorea. Am J Psychiatry. 1989 Feb;146(2):246–249.
   PubMed Web of Science ®Google Scholar
• Swedo SE, Leonard HL, Schapiro MB, et al. Sydenham’s chorea: physical and psychological symptoms of St Vitus dance. Pediatrics. 1993 Apr;91(4):706–713.
   PubMed Web of Science ®Google Scholar
• Asbahr FR, Garvey MA, Snider LA, et al. Obsessive-compulsive symptoms among patients with Sydenham chorea. Biol Psychiatry. 2005 May 1;57(9):1073–1076.
   PubMed Web of Science ®Google Scholar
• Maia DP, Teixeira AL Jr., Quintao Cunningham MC, et al. Obsessive compulsive behavior, hyperactivity, and attention deficit disorder in Sydenham chorea. Neurology. 2005 May 24;64(10):1799–1801.
   PubMed Web of Science ®Google Scholar
• Hounie AG, Pauls DL, Mercadante MT, et al. Obsessive-compulsive spectrum disorders in rheumatic fever with and without Sydenham’s chorea. J Clin Psychiatry. 2004 Jul;65(7):994–999.
   PubMed Web of Science ®Google Scholar
• Moreira J, Kummer A, Harsanyi E, et al. Psychiatric disorders in persistent and remitted Sydenham’s chorea. Parkinsonism Relat Disord. 2014 Feb;20(2):233–236.
   PubMed Web of Science ®Google Scholar
• Mercadante MT, Busatto GF, Lombroso PJ, et al. The psychiatric symptoms of rheumatic fever. Am J Psychiatry. 2000 Dec;157(12):2036–2038.
   PubMed Web of Science ®Google Scholar
• de Alvarenga PG, Floresi AC, Torres AR, et al. Higher prevalence of obsessive-compulsive spectrum disorders in rheumatic fever. Gen Hosp Psychiatry. 2009 Mar-Apr;31(2):178–180.
   PubMed Web of Science ®Google Scholar
• Teixeira AL, Athayde GR, Sacramento DR, et al. Depressive and anxiety symptoms in Sydenham’s chorea. Mov Disord. 2007 Apr 30;22(6):905–906.
   PubMed Web of Science ®Google Scholar
• Swedo SE, Leonard HL, Garvey M, et al. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases. Am J Psychiatry. 1998 Feb;155(2):264–271.
   PubMed Web of Science ®Google Scholar
• Garvey MA, Giedd J, Swedo SE. PANDAS: the search for environmental triggers of pediatric neuropsychiatric disorders Lessons from rheumatic fever. J Child Neurol. 1998 Sep;13(9):413–423.
   PubMed Web of Science ®Google Scholar
• Gilbert DL. Inflammation in Tic Disorders and Obsessive-Compulsive Disorder: are PANS and PANDAS a Path Forward? J Child Neurol. 2019 Sep;34(10):598–611.
   PubMed Web of Science ®Google Scholar
• Wilbur C, Bitnun A, Kronenberg S, et al. PANDAS/PANS in childhood: controversies and evidence. Paediatr Child Health. 2019 May;24(2):85–91.
   PubMed Web of Science ®Google Scholar
• Cunningham MC, Maia DP, Teixeira AL Jr., et al. Sydenham’s chorea is associated with decreased verbal fluency. Parkinsonism Relat Disord. 2006 Apr;12(3):165–167.
   PubMed Web of Science ®Google Scholar
• Beato R, Maia DP, Teixeira AL Jr., et al. Executive functioning in adult patients with Sydenham’s chorea. Mov Disord. 2010 May 15;25(7):853–857.
   PubMed Web of Science ®Google Scholar
• Cavalcanti A, Hilario MO, dos Santos FH, et al. Subtle cognitive deficits in adults with a previous history of Sydenham’s chorea during childhood. Arthritis Care Res (Hoboken). 2010 Aug;62(8):1065–1071.
   PubMed Web of Science ®Google Scholar
• Harsanyi E, Moreira J, Kummer A, et al. Language impairment in adolescents with sydenham chorea. Pediatr Neurol. 2015 Nov;53(5):412–416.
   PubMed Web of Science ®Google Scholar
• Gurkas E, Karalok ZS, Taskin BD, et al. Predictors of recurrence in Sydenham’s chorea: clinical observation from a single center. Brain Dev. 2016 Oct;38(9):827–834.
   PubMed Web of Science ®Google Scholar
• Cardoso F, Vargas AP, Oliveira LD, et al. Persistent Sydenham’s chorea. Mov Disord. 1999 Sep;14(5):805–807.
   PubMed Web of Science ®Google Scholar
• Korn-Lubetzki I, Brand A, Steiner I. Recurrence of Sydenham chorea: implications for pathogenesis. Arch Neurol. 2004 Aug;61(8):1261–1264.
   PubMedGoogle Scholar
• Maia DP, Fonseca PG, Camargos ST, et al. Pregnancy in patients with Sydenham’s Chorea. Parkinsonism Relat Disord. 2012 Jun;18(5):458–461.
   PubMed Web of Science ®Google Scholar
• Leal M, Passos LSA, Guarconi FV, et al. Rheumatic heart disease in the modern era: recent developments and current challenges. Rev Soc Bras Med Trop. 2019 Mar;52(52):e20180041.
   PubMedGoogle Scholar
• Carapetis JR, Beaton A, Cunningham MW, et al. Acute rheumatic fever and rheumatic heart disease. Nat Rev Dis Primers. 2016 Jan;14(2):15084.
   Google Scholar
• Gerber MA, Baltimore RS, Eaton CB, et al. Prevention of rheumatic fever and diagnosis and treatment of acute Streptococcal pharyngitis: a scientific statement from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young, the Interdisciplinary Council on Functional Genomics and Translational Biology, and the Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics. Circulation. 2009 Mar 24;119(11):1541–1551.
   PubMed Web of Science ®Google Scholar
• Appleton RE, Jan JE. Efficacy of valproic acid in the treatment of Sydenham’s chorea. J Child Neurol. 1988 Apr;3(2):147.
   PubMedGoogle Scholar
• Daoud AS, Zaki M, Shakir R, et al. Effectiveness of sodium valproate in the treatment of Sydenham’s chorea. Neurology. 1990;40(7):1140–1141.
   PubMed Web of Science ®Google Scholar
• Harel L, Zecharia A, Straussberg R, et al. Successful treatment of rheumatic chorea with carbamazepine. Pediatr Neurol. 2000;23(2):147–151.
   PubMed Web of Science ®Google Scholar
• Genel F, Arslanoglu S, Uran N, et al. Sydenham’s chorea: clinical findings and comparison of the efficacies of sodium valproate and carbamazepine regimens. Brain Dev. 2002;24(2):73–76.
   PubMed Web of Science ®Google Scholar
• Peña J, Mora E, Cardozo J, et al. Comparison of the efficacy of carbamazepine, haloperidol and valproic acid in the treatment of children with Sydenham’s chorea: clinical follow-up of 18 patients. Arquivos de neuro-psiquiatria. 2002;60(2B):374–377.
   PubMed Web of Science ®Google Scholar
• Sethi S, Setiya R, Lallar K. Successful treatment of Sydenham chorea with olanzapine. J Paediatr Neurol. 2015;07/29(4):171–174.
   Google Scholar
• Sahin S, Cansu A, New Alternative A. Drug With Fewer Adverse Effects in the Treatment of Sydenham Chorea: levetiracetam Efficacy in a Child. Clin Neuropharmacol. 2015 Jul-Aug;38(4):144–146.
   PubMed Web of Science ®Google Scholar
• Yilmaz S, Mink JW. Treatment of Chorea in Childhood. Pediatr Neurol. 2020 Jan;102:10–19.
   PubMed Web of Science ®Google Scholar
• Walker KG, Wilmshurst JM. An update on the treatment of Sydenham’s chorea: the evidence for established and evolving interventions. Ther Adv Neurol Disord. 2010 Sep;3(5):301–309.
   PubMedGoogle Scholar
• Direk M, Epcacan S, Epcacan Z, et al. Efficacy of levetiracetam in the treatment of Sydenham chorea. Pediatr Int. 2020 Nov;62(11):1264–1268.
   PubMed Web of Science ®Google Scholar
• Demiroren K, Yavuz H, Cam L, et al. Sydenham’s chorea: a clinical follow-up of 65 patients. J Child Neurol. 2007;22(5):550–554.
   PubMed Web of Science ®Google Scholar
• Salem H, Pigott T, Zhang XY, et al. Antipsychotic-induced Tardive dyskinesia: from biological basis to clinical management. Expert Rev Neurother. 2017 Sep;17(9):883–894.
   PubMed Web of Science ®Google Scholar
• Miranda M, Walker RH, Saez D, et al. Severe Sydenham’s chorea (chorea paralytica) successfully treated with plasmapheresis. J Clin Mov Disord. 2015;2(1):2.
   PubMedGoogle Scholar
• Green LN. Corticosteroids in the treatment of Sydenham’s chorea. Arch Neurol. 1978;35(1):53–54.
   PubMedGoogle Scholar
• Cardoso F, Maia D, Cunningham MCQS, et al. Treatment of Sydenham chorea with corticosteroids. Mov Disord. 2003;18(11):1374–1377.
   PubMed Web of Science ®Google Scholar
• Barash J, Margalith D, Matitiau A. Corticosteroid treatment in patients with Sydenham’s chorea. Pediatr Neurol. 2005 Mar;32(3):205–207.
   PubMed Web of Science ®Google Scholar
• Garvey MA, Snider LA, Leitman SF, et al. Treatment of Sydenham’s chorea with intravenous immunoglobulin, plasma exchange, or prednisone. J Child Neurol. 2005;20(5):424–429.
   PubMed Web of Science ®Google Scholar
• Paz JA, Silva CA, Marques-Dias MJ. Randomized double-blind study with prednisone in Sydenham’s chorea. Pediatr Neurol. 2006 Apr;34(4):264–269.
   PubMed Web of Science ®Google Scholar
• Favaretto E, Gortani G, Simonini G, et al. Preliminary data on prednisone effectiveness in children with Sydenham chorea. Eur J Pediatr. 2020 Jun;179(6):993–997.
   PubMed Web of Science ®Google Scholar
• Fusco C, Ucchino V, Frattini D, et al. Acute and chronic corticosteroid treatment of ten patients with paralytic form of Sydenham’s chorea. Eur J Paediatr Neurol. 2012 Jul;16(4):373–378.
   PubMed Web of Science ®Google Scholar
• Fusco C, Spagnoli C. Corticosteroid treatment in Sydenham’s chorea. Eur J Paediatr Neurol. 2018 Mar;22(2):327–331.
   PubMed Web of Science ®Google Scholar
• Teixeira AL, Jr., Maia DP, Cardoso F. Treatment of acute Sydenham's chorea with methyl-prednisolone pulse-therapy. Parkinsonism Relat Disord. 2005 Aug;11(5):327–330.
   PubMed Web of Science ®Google Scholar
• van Immerzeel TD, Van Gilst RM, Hartwig NG. Beneficial use of immunoglobulins in the treatment of Sydenham chorea. Eur J Pediatr. 2010 Sep;169(9):1151–1154.
   PubMed Web of Science ®Google Scholar
• Boersma NA, Schippers H, Kuijpers T, et al. Successful treatment of Sydenham’s chorea with intravenous immunoglobulin. BMJ Case Rep. 2016;2016:bcr2015211673.
   PubMedGoogle Scholar
• Mohammad SS, Nosadini M, Grattan-Smith P, et al. Intravenous immunoglobulin in acute Sydenham’s chorea: a systematic review. J Paediatr Child Health. 2015 Dec;51(12):1235–1238.
   PubMed Web of Science ®Google Scholar
• Walker K, Brink A, Lawrenson J, et al. Treatment of sydenham chorea with intravenous immunoglobulin. J Child Neurol. 2012 Feb;27(2):147–155.
   PubMed Web of Science ®Google Scholar
• Gregorowski C, Lochner C, Martin L, et al. Neuropsychological manifestations in children with Sydenham’s chorea after adjunct intravenous immunoglobulin and standard treatment. Metab Brain Dis. 2016 Feb;31(1):205–212.
   PubMed Web of Science ®Google Scholar